Literature DB >> 17270311

Risk adjustment and risk selection in Europe: 6 years later.

Wynand P M M van de Ven1, Konstantin Beck, Carine Van de Voorde, Jürgen Wasem, Irit Zmora.   

Abstract

In this paper we analyse the developments concerning risk adjustment and risk selection in Belgium, Germany, Israel, the Netherlands and Switzerland in the period 2000-2006. Since 2000 two major trends can be observed. On the one hand the risk adjustment systems have been improved, for example, by adding relevant health-based risk adjusters. On the other hand in all five countries there is evidence of increasing risk selection, which increasingly becomes a problem, in particular in Germany and Switzerland. Some potential explanations are given for these seemingly contradictory observations. Since the mid-1990s citizens in these countries can regularly switch sickness fund, which should stimulate the sickness funds to improve efficiency in health care production and to respond to consumers' preferences. When looking at managed care there are some weak signals of increasing managed care activities by individual sickness funds in all countries (except Belgium). However, with imperfect risk adjustment, such as in Israel and Switzerland, insurers will integrate their managed care activities with their selection activities, which may have adverse effects for society, even if all insurers are equally successful in selection. The conclusion is that good risk adjustment is an essential pre-condition for reaping the benefits of a competitive health insurance market. Without good risk adjustment the disadvantages of a competitive insurance market may outweigh its advantages.

Mesh:

Year:  2007        PMID: 17270311     DOI: 10.1016/j.healthpol.2006.12.004

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  13 in total

1.  The potential premium range of risk-rating in competitive markets for supplementary health insurance.

Authors:  Francesco Paolucci; Femmeke Prinsze; Pieter J A Stam; Wynand P M M van de Ven
Journal:  Int J Health Care Finance Econ       Date:  2009-01-06

2.  Spatial risk adjustment between health insurances: using GWR in risk adjustment models to conserve incentives for service optimisation and reduce MAUP.

Authors:  Danny Wende
Journal:  Eur J Health Econ       Date:  2019-06-13

3.  Modest risk-sharing significantly reduces health plans' incentives for service distortion.

Authors:  Shuli Brammli-Greenberg; Jacob Glazer; Ruth Waitzberg
Journal:  Eur J Health Econ       Date:  2019-08-22

4.  Spillover effects of supplementary on basic health insurance: evidence from The Netherlands.

Authors:  Anne-Fleur Roos; Frederik T Schut
Journal:  Eur J Health Econ       Date:  2010-09-23

5.  An empirical investigation of the efficiency effects of integrated care models in Switzerland.

Authors:  Oliver Reich; Roland Rapold; Magdalena Flatscher-Thöni
Journal:  Int J Integr Care       Date:  2012-01-13       Impact factor: 5.120

6.  Predictive risk modelling in the Spanish population: a cross-sectional study.

Authors:  Juan F Orueta; Roberto Nuño-Solinis; Maider Mateos; Itziar Vergara; Gonzalo Grandes; Santiago Esnaola
Journal:  BMC Health Serv Res       Date:  2013-07-09       Impact factor: 2.655

7.  How are population-based funding formulae for healthcare composed? A comparative analysis of seven models.

Authors:  Erin Penno; Robin Gauld; Rick Audas
Journal:  BMC Health Serv Res       Date:  2013-11-08       Impact factor: 2.655

8.  A Review on Methods of Risk Adjustment and their Use in Integrated Healthcare Systems.

Authors:  Christin Juhnke; Susanne Bethge; Axel C Mühlbacher
Journal:  Int J Integr Care       Date:  2016-10-26       Impact factor: 5.120

9.  Chronic morbidity, deprivation and primary medical care spending in England in 2015-16: a cross-sectional spatial analysis.

Authors:  Evangelos Kontopantelis; Mamas A Mamas; Harm van Marwijk; Andrew M Ryan; Peter Bower; Bruce Guthrie; Tim Doran
Journal:  BMC Med       Date:  2018-02-14       Impact factor: 8.775

10.  How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.

Authors:  Wynand P M M van de Ven; René C J A van Vliet; Richard C van Kleef
Journal:  Eur J Health Econ       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.